{
    "root": "a6d48e99-4411-4724-8372-b01692a5dff7",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "ambrisentan"
    },
    "value": "20250421",
    "ingredients": [
        {
            "name": "AMBRISENTAN",
            "code": "HW6NV07QEC"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients:\n                  \n                  \n                     To improve exercise ability and delay clinical worsening.\n                  \n                  Studies establishing effectiveness included predominantly patients with WHO Functional Class II to III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%).",
    "contraindications": "• Initiate treatment at 5 mg once daily ( 2.1 ). • Titrate at 4-week intervals as needed and tolerated ( 2.1 ). • Do not split, crush, or chew tablets ( 2.1 ).",
    "warningsAndPrecautions": "Ambrisentan Tablets 5 mg are pale pink, film-coated, square shaped convex tablets debossed with “AS” on one side and “5” on other side and are supplied as follows:\n                  \n                  Bottles of 30                                       NDC   59651-494-30\n                  \n                  \n                     Ambrisentan Tablets 10 mg are deep pink, film-coated, oval shaped convex tablets debossed with “AS” on one side and “10” on other side and are supplied as follows:\n                  \n                  Bottles of 30                                       NDC   59651-495-30\n                  \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Store ambrisentan tablets in its original packaging.",
    "adverseReactions": "Pregnancy ( 4.1 ) Idiopathic Pulmonary Fibrosis ( 4.2 )"
}